ADPTAdaptive Biotechnologies Corp

$27.29
$0.02 (0%)

Create a FREE Account to View Full Report

Analyst ForecastNext 12 months ➝Current Price$27.2952-week High$55.1252-week Low$24.05MEAN$45.75+67.64%HIGH$47.00+72.22%LOW$45.00+64.90%
  • Last Price$27.29
  • Previous Close$27.27
  • Change $0.02
  • Open$27.45
  • Volume548,428
  • Avg. Volume (100-day)0
  • Market Capitalization$3.39B
  • Days Range $26.13 - $27.50
  • 52-week Range $24.05 - $55.12
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-2.89
  • Earnings Date02/11/2020
  • SectorHealthcare
  • IndustryBiotechnology
  • Avg. Analyst Rec.
  • Beta4.265
  • PEG Ratio
  • Volatility0.88
  • Average True Range0.10
Adaptive Biotechnologies Corp is a a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.